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The mammalian target of rapamycine (mTOR) pathway is a key regulator of cellular growth,
development, and ageing, and unraveling its control is essential for understanding life
and death of biological organisms. A motif-discovery workbench including nine tools
was used to identify transcription factors involved in five basic (Insulin, MAPK, VEGF,
Hypoxia, and mTOR core) activities of the mTOR pathway. Discovered transcription factors
are classified as “process-specific” or “pathway-ubiquitous” with highlights toward their
regulating/regulated activities within the mTOR pathway. Our transcription regulation
results will facilitate further research on investigating the control mechanism in mTOR
pathway.
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INTRODUCTION
Computational analysis of transcription regulation of biolog-
ical pathways is a challenging task because a single pathway
may be interconnected to multiple upstream and downstream
pathways and, as a consequence, might be regulated by various
groups of transcription factors (Schmelzle and Hall, 2000; Hay
and Sonenberg, 2004; Inoki and Guan, 2006; Polouliakh et al.,
2006, 2009; Laplante and Sabatini, 2009; Caron et al., 2010).
Because the transcriptional level is a fundamental mechanism
that is well conserved in all cellular systems, a cross-species com-
parison approach should increase the confidence of the analysis.
A further way to reduce false positives is to combine the consistent
part of the results obtained on multiple analytic tools.
In this work, a transcription regulation network of ortholo-
gous human-mouse mTOR (mammalian target of rapamycin)
pathway genes was investigated by using nine public motif-
discovery tools published in the last decade. TOR was first
discovered in yeast (Heitman et al., 1991), then identified as evo-
lutionarily conserved (Brown et al., 1994; Sabatini et al., 1994),
and finally functionally characterized in fungi yeast (Lorberg and
Hall, 2004), animals (Hall, 2008), and plants (Deprost et al.,
2007). It has a high molecular weight and several distinctive
domains. In particular, mTOR consists of 2549 amino acids and
possesses a kinase domain at the C terminal, which displays
homology to the phosphatidylinositol 3-kinase (PI3K) catalytic
domain. PIK–related kinases are responsible for numerous cel-
lular processes, e.g., cell growth and development, DNA-damage
detection, and telomere maintenance (Schmelzle and Hall, 2000;
Hay and Sonenberg, 2004). Because of its structure, mTOR
can create two functional protein complexes with two other
proteins: one with MLST8 and RICTOR and one with MLST and
RPTOR. Since it can form such structures, mTOR has to be ana-
lyzed in the context of a wider signaling network (Inoki et al.,
2005).
An mTOR pathway is an important regulator of
embryogenesis, angiogenesis, adipogenesis, autophagy, and
cell cycle. It can be divided into several branches responsible for
actin and microtubule organization, protein and lipid synthesis,
cell growth and cell differentiation, and autophagy (Laplante
and Sabatini, 2009). In addition, the involvement of an mTOR
pathway in the aging process and pathological changes such as
tumor formation, cancer, insulin resistance, and diabetes has
been pointed out by many researches (Laplante and Sabatini,
2009; Stanfel et al., 2009; Caron et al., 2010). What’s more,
disruption of genes from mTOR pathway (e.g., TSC1, TSC2,
and TOR) results in early embryonic death both in Drosophilla
and mammals, suggesting that TOR plays a crucial role in the
development (Kobayashi et al., 2001; Murakami et al., 2004;
Inoki et al., 2005). In humans, cell hypertrophy, hyper-function
and hyperplasia, typically associated with activation of mTOR,
contribute to diseases associated with aging, such as myocardial
infarctions and strokes, osteoporosis, cancer, autoimmune
disease, arthritis, obesity, diabetes, macula-degeneration, and
Alzheimer’s and Parkinson’s diseases (Blagosklonny, 2006;
Johnson et al., 2013; O’Neill and Hardie, 2013).
An mTOR pathway is regulated by various signals. It can be
activated by availability of amino acids and nutrients, presence of
growth factors and hormones, and it may be halted by the action
of such factors as energy stress, hypoxia, and osmotic changes
(Inoki et al., 2005; Inoki and Guan, 2006; Caron et al., 2010). It is
also regulated by the level of gene expression, which is controlled
by transcription factors (TFs) within the pathway.
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When investigating transcription regulation, it is necessary to
consider both the comparatively short promoter regions in the
proximity of a transcriptional start site (TSS), where the poly-
merase II transcription initiation complex forms, and distantly
located enhancer regions that may interact with one or more
promoter sites of neighboring genes (Serizawa et al., 2003) and
whose distance from the TSS can exceed 100 kb.
Given that scientific tools can be difficult to install, it is
particularly helpful for biologists to be able to use these tools
through a web-user interface. Our investigations were focused
on tools available online and showed that nine out of thirty-two
tested online motif discovery programs are easy and suitable for
the analysis, while others should be handled offline or require
additional data management.
As a result of our study with selected tools, 61 transcrip-
tion factors for human and 50 transcription factors for mouse
were identified, and 24 and 13 transcription factors, respectively,
were then selected for the discussion on their activity in mTOR
pathway. Twenty-one transcription factors between human and
mouse were orthologous, and the 13 most frequent of them are
discussed in this paper.
Transcription factors regulating an mTOR pathway and tran-
scription factors regulated by an mTOR pathway are indicated
separately. We believe that the created transcription regulation
map can extend the knowledge from already verified transcrip-
tion factors to the new hypothesis of transcription regulation
of an mTOR pathway including feedback loops. Our guidance
on a bunch of recent motif-discovery tools will be helpful for a
large scope of audience and should trigger further discussion on
optimization of tools and analysis workflow (Ghosh et al., 2011).
MATERIALS AND METHODS
mTOR PATHWAY GENE DATASET
The mTOR human pathway was downloaded from the KEGG
database (map04150) and included 49 human genes with 43
orthologous partners in mouse. Promoter regions of 5000 base
pairs upstream and 500 base pairs downstream with their repre-
sentative transcriptional start sites (TSS) were retrieved from the
DBTSS database (Yamashita et al., 2010).
MOTIF DISCOVERY TOOLS AND MOTIF SELECTION
Thirty-one non-commercial online motif-discovery programs,
which are already popular for the analysis of biological data or
were newly developed in the last decade, were investigated. In our
set of tools we included programs that could analysis ortholo-
gous promoters (e.g., Pscan, TransFind), programs with diverse
methodologies (e.g., MEME_Chip, TFM-explorer, Pscan) and
programs that link the results to the expression data to augment
probability likelihood of predicted motifs (e.g., MEME_Chip,
PASTAA, TRAP). Next, each of selected program had to fulfill
the following four characteristics: (1) capability to handle a large
data size (300Kb) and return results in less than 24 h; (2) report
motif results for each DNA sequence or report motif results across
the whole dataset; (3) execute a software operation without man-
ual parameter adjustment; and (4) annotate resulted motifs in
currently available databases.
Five main programs, which report identified motifs in each
sequence, namely, Pscan (Zambelli et al., 2009), PASTAA (Roider
et al., 2009), MEME_Chip (Machanick and Bailey, 2011),
TFM-Explorer (Defrance and Touzet, 2006), and XXmotif (Luehr
et al., 2012) were selected, and four supportive programs, which
report motifs over a whole dataset, namely, Cscan (Zambelli et al.,
2012), LocaMo (Vandenbon et al., 2013), TransFind (Kielbasa
et al., 2010), and TRAP (Roider et al., 2007), were selected.
All programs were executed in their default parameter setting.
Table 1 lists features of the nine programs used for the analysis.
Twenty-two online programs that were investigated and found
unsuitable for our analysis are listed as follows: BioProspector
(Liu et al., 2001), CompareProspector (Liu et al., 2004),
CompMoby (Chaivorapol et al., 2008), ConTra (Broos et al.,
2011;) ConSite (Sandelin et al., 2004), Improbizer (Ao et al.,
2004), Gibbs Motif Sampler (Thompson et al., 2003), Lasagna
(Lee and Huang, 2013), MDScan (Liu et al., 2002), Melina
(Poluliakh et al., 2003), MEME (Bailey et al., 2009), Mobyle
@Pasteur tfscan (Néron et al., 2009), MotifSearch (Dinh et al.,
2011), MotifViz (Fu et al., 2004), MotifVoter (Wijaya et al., 2008),
PhyloGibbs (Siddharthan et al., 2005), RSAT consensus, rVista
(Loots andOvcharenko, 2004), SeSiMCMC (Favorov et al., 2005),
SCOPE (Carlson et al., 2007), WebMOTIFS (Romer et al., 2007),
and YMF (Sinha and Tompa, 2003).
Initial motifs were collected in accordance with two con-
ditions: first, each of the five main selected programs should
identify a motif and, second, some supportive programs should
also find the same motif. Details of collected motifs are repre-
sented in Supporting Figure 1, together with their target genes
and software programs used.
To find the most co-regulated genes within the dataset, the
average number of transcription factors per gene was calcu-
lated by dividing the total number of TFBS motifs found by
PScan, PASTAA, MEME_Chip, TFM-Explorer, and XXmotif in
a human dataset (1,295), by the total number of genes in
the human dataset (49) that resulted in 26.43 (SD± 7.87)
transcription-factor motifs per gene, shown above the red hor-
izontal line in Supporting Figure 1A, hereafter called a gene
threshold (Gene_TH). This resulted in 24 genes, possessing more
than 26 predicted motifs in their promoters for human, including
their multiple occurrences.
The top 24 out of 61 (40%) human transcription factors
found in the promoters of genes above the gene threshold were
taken and denoted as those above a transcription factor thresh-
old (TF_TH). This selection showed that at least half of the 24
genes possessed each of the 24 above-selected transcription-factor
motifs in their promoters. The top-occurring transcription fac-
tors was SP1 with its highest frequency and top occurrence of
seven copies in the RPS6KA3 gene, and the last-occurring tran-
scription factor was ARNT found in 12 genes with single occur-
rence (Supporting Figure 1A). This 24-by-24 matrix is named an
intersection zone.
The intersection zone was used to produce an mTOR map by
CellDesigner4.3 (Funahashi et al., 2003) with those TFs having
multiple copies in the promoters or those TFs already men-
tioned in the literature in relation to mTOR (Figure 1). The
transcription-regulation map was divided into an mTOR core
and ten modules for convenience to point out to the transcrip-
tion factors involved in different activities of the mTOR path-
way. Modules were then classified into pre-core transcriptional
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modules and post-core transcriptional modules according to their
place within the pathway.
Transcription factors were classified as those that regu-
late the mTOR pathway and those that are regulated by
the mTOR pathway, representing them in green and/or red
circles on the map in Figure 1. Newly identified TFs are
shown in gray circles with a respective color rim depend-
ing on their role in the mTOR pathway. Human genes with-
out orthologs in mice are shown in gray squares on the map
(Figure 1). The intersection zone for human is extended to
mouse data to see commonalities between the two species
(Supporting Figures 1A,B).
RESULTS
mTOR-PATHWAY TRANSCRIPTION FACTORS
Transcription factors (TF) and genes allocated in the intersec-
tion zone (seeMethods) were selected as candidates for regulating
an mTOR pathway. The initial identified number of TFs was 61
for human and 50 for mouse with 21 orthologs (Figure 1 and
Supporting Figure 1). Nine transcription factors identified in our
study were already assigned to the activities of an mTOR path-
way, but their target genes were not specified. Those TFs are
following: SP1, KLF4, TBP, ELK1, ESR1, E2F1, FOXF2, EGR1,
and ARNT, shown with respective green or red colors in Figure 1
according to their regulating or regulated role for in regard to an
mTOR pathway. TFs having orthologous bindingmotifs inmouse
are marked in Supporting Figure 1C with asterisks. Previously
unknown transcription factors identified in our study in mTOR-
pathway genes are shown in gray on the map in Figure 1. We
found particularly interesting those TFs with number of bind-
ing sites exceeding three occurrences per gene, i.e., high-affinity
TFs, and those appearing in more than a half of the promoters of
genes in the dataset, i.e., in our intersection zone (see Methods).
Activities of various modules with assigned transcription factors
are discussed in the next sub-sections.
mTOR CORE, PRE-CORE, POST-CORE TRANSCRIPTIONAL MODULES
The pre-core mTOR modules are listed as following: mod-
ule 1—induced by growth factors and hormones possessing
MAPK cascade and RPS6K genes; module 2—activated by growth
factors and hormones and involved in insulin signaling pathway
associated with PIK3 genes and AKT genes; module 3—regulated
by extracellular amino acids and TNF; module 4—possessing
hypoxia dependent genes; module 5—connected with the bal-
ance of amino acids inside the cell and related to the RRAG gene
group; module 9—linked with cell differentiation; module 10—
containing energy-stress-related genes such as CAB3, STRADA,
and STK11 as well as genes influenced by drug administration.
Post-core transcriptional modules are listed as follows: mod-
ule 6—associated with actin organization; module 7—connected
to VEGF pathway conducting cell development and growth; and
module 8—modulating autophagy. As an mTOR pathway core,
an RHEB gene and two blocks of genes with MTOR-RICTOR
and MTOR-RPTOR interacting pairs, respectively, is considered.
Modules 3, 6, 8, and 9 are shown on the map in Figure 1, but they
are not discussed in this paper because no reliable motifs were
identified in our study.
MODULE ONE OF MAPK-SIGNALING PATHWAY AND MODULE TWO OF
INSULIN-SIGNALING PATHWAY
In module 1, which embodies MAPK signaling pathway, five tran-
scription factors were identified. Two of them, ESR1 and ELK1,
are already known, and three newly identified in our study are
SP1, MZF1 (myeloid zinc finger 1), and PLAG1 (Pleiomorphic
adenoma gene 1 protein).
Both ELK1 (an ETS domain-containing protein) and ESR1
(a nuclear steroid receptor) interact with the MAPK3 gene
(Polouliakh et al., 2006). ELK1 is a nuclear target for a MAPK
cascade (Uht et al., 2007). ESR1 is a homodimer composed of sev-
eral domains crucial for hormone binding and form heterodimers
with ESR2 (estrogen receptor 2). In the mTOR pathway, ESR1 is
inhibited by phosphophorylation regulated by RPS6KB1 (S6K1)
from a VEGF signaling pathway and a MAPK pathway (Yamnik
and Holz, 2010) (module 7). Inhibition of ESR1 affects activa-
tion of S6K1/2 and stimulates phosphorylation of S6K1/2 and
4EBP in the presence of Leucine. ELK1 and ESR1 are regulated
by a mTOR MAPK signaling pathway and a VEGF angiogenesis
signaling pathway with crosstalk.
SP1 is the most abundant inmodules 1 and 2 as well as in other
parts of the mTOR pathway. SP1 is a zinc finger protein and binds
to motifs rich in GC content in various promoter regions to sus-
tain an open chromatin structure of DNA. SP1 regulates various
processes of mTOR pathway, which are cell differentiation, cell
growth, apoptosis, immune responses, response to DNA damage,
and chromatin remodeling. The allocations of binding motifs for
SP1 within promoters of genes in the mTOR pathway suggest the
strong possibility of both regulating and regulated statuses of SP1
in the mTOR pathway.
Discovering SP1 in EIF4E1B in module 7 of the mTOR
pathway proves the above-mentioned suggestion. EIF4E1B is an
inhibitor of eukaryotic translation initiation factor EIF4E—a
group of genes involved in mRNA activation, protein synthesis,
and cell development (Li et al., 2012). Moreover, in the mTOR
pathway, SP1 interacts with hypoxia inducible factor HIF1, trans-
activating vascular endothelial growth factor (VEGF) regulating
the VEGF pathway (module 7) and influencing autophagy (mod-
ule 8) (Alam et al., 2004).
A myeloid-zinc-finger (MZF1) TF function, which is a granu-
locyte precursor in bone marrow, in the mTOR pathway is not
yet discovered. Found in the multiple promoters of module 1
it can be presumed that MZF1 changes the transcription inside
the pathway by influencing INS (dependent on growth factors
and hormones) or by regulating the MAPK cascade and RPS6K
gene (module 1). Moreover, MZF1 is also involved in activating or
deactivating the PTEN gene, which is known as a tumor suppres-
sor (module 2). MZF1 binding motifs were also found in VEGFA
promoter, suggesting regulation of the VEGF pathway (module 7),
in E1F4E1B promoter implying involvement in cell development
(module 7), and in ULK1 promoter indicating connection with
autophagy process in mTOR (module 8) [27]. Accordingly, MZF1
is a ubiquitous plays an important role in regulation of the whole
mTOR pathway.
The third transcription factor contributing largely to the pre-
core modules one and two is PLAG1 (pleiomorphic adenoma
gene 1 protein). It regulates a range of mTOR processes involved
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in cell proliferation, organ growth, and apoptosis. In our research,
it is found in the promoters of INS, RPS6KA2 (module 1), IRS1,
PIK3R1, PIK3CA (module 2), TNF (module 3), and TSC2 (mod-
ule 4). Akhtar et al. (2012) suggest that PLAG1 is overexpressed in
cancer cells when it binds to IGF2 promoter. Because of the close
proximity of the IRS1 and IGF genes, PLAG1 may also regulate
IRS1 as it was identified in our research.
Pre-core modules 1 (MAPK signaling) and 2 (Insulin signal-
ing) share SP1, MZF1, and PLAG1 transcription factors. Apart
from it, module 2 has FOXF2 (forkhead box F2) and TBP (TATA-
binding protein). FOXF2 and TBP are already known in the
context of co-regulation with MTOR, RDS1, (adenine-repressible
gene) and TFAP2A (transcription factor AP-2 alpha) (Westergren,
2010).
FOXF2 is classified as TF, which regulates the mTOR pathway.
The increased amount of FOXF2 inhibits the activity of IRS1
(insulin receptor substrate 1), leading to inhibition of the whole
mTOR pathway via a negative-feedback loop (Westergren, 2010).
FOXF2 interacts with another transcription factor TBP (TATA-
binding protein), and in our research, both of them were found in
close proximity to IRS1. TBP additionally interacts with SP1 and
E2F1 transcription factors found in the intersection zone of mostly
interconnected genes in our study (Supporting Figure 1A). In
module 2, TBP is regulated by PI3K genes, and in the mTOR core,
TBP is regulated by the MTOR gene, thus, playing a vital role in
recruiting Polymerase I and modulating activity of Polymerase
III (Cianfrocco et al., 2013).
In consideration of the locations of TFAP2A binding motifs,
it is noteworthy that TFAP2A can regulate the mTOR path-
way and, in particular, its core path. A TFAP2A binding motif
was found in the promoters of IRS1 and PIK3R2 genes of an
insulin signaling pathway (module 2), a PTEN gene, which is an
inhibitor of the mTOR pathway thought the PIP3 (module 2)
and RRAGD genes (module 5). TFAP2A is thus involved in pro-
cesses of organ development and negative cell proliferation at the
same time. One of the probable scenarios concerning TFAP2A
is that by inhibition of IRS1, PIK3R2 (module 2), and RRAGD
(module 5) genes, TFAP2A stimulates the PTEN transcription
immobilizing mTOR pathway and negative feedback loop may
exist between insulin-signaling module 2 and amino-acid balance
module 5. Surprisingly, a TF characteristic for yeast RDS1 (an
adenine-repressible gene), responsible for the regulation of tran-
scription fromRNA polymerase II, is identified in the human data
set. RDS1 binding motif is found in the promoters of IRS1, AKT1
(threonine-protein kinase) genes of pre-core module 2, and the
RRAGC (Ras-related GTP binding C) gene of post-coremodule 5.
It is difficult to assess RDS1 functions in an mTOR pathway due
to the fact that it is only been found in yeast to date. However, in
yeast organisms, it is responsible for transcription regulation and
response to xenobiotic stimulus. In human organisms, its func-
tion may be very similar to the function in yeast, and human
ortholog might be identified in the future.
RDS1 can influence the mTOR pathway from two sides:
first, being regulated by growth factors and hormones (IRS1
and AKT1 in module 2) and, second, being regulated by the
availability of amino acids or generally intracellular xenobiotics
(RRAGC in module 5). The above-described finding on RDS1
activity indicates the existence of crosstalk between module 2
(insulin signaling) and module 5 (amino-acid balance within a
cell) transcription regulation and existence of a negative feed-
back loop between them. This is a biologically reasonable finding
as insulin-control amino-acid metabolism is tightly related to
amino-acid-uptake balance.
MODULE FOUR REGULATES HYPOXIA
ARNT (aryl-hydrocarbon receptor nuclear translocator 3,
HIF-1β) is one that regulates gene expression in hypoxia module
4. It encodes a protein that is crucial for complex formation
with the ligand-bound aryl hydrocarbon receptor (AHR) and
proper functioning of this receptor. Current knowledge indicates
that the HIF1- and/or HIF2-mediated hypoxia responses can
be oncogenic as well as tumor suppressive (Pawlis and Hu,
2013). ARNT induces activation of REDD1 (DDIT4) by creating
a dimer with HIF1, thereby inhibiting TORC1 and affecting
the TSC2-depending mechanism (Kapahi et al., 2010). ARNT
interacts with ESR1, co-activating its transcription (Endler
et al., 2004), and with SP1, creating a reconstituent complex
(Mulero-Navarro et al., 2006) with it. SP1 itself is able to bind the
Ah receptor and down-regulates its expression in leukemia cells
(Mulero-Navarro et al., 2006).
CORE MODULE OF mTOR
In the core of mTOR pathway KLF4 (Kruppel-like factor 4)
inhibits the MTOR gene and has an anti-proliferative effect on
the whole mTOR pathway (Wang et al., 2012), thereby promoting
self-renewal and precluding differentiation.
On the contrary, MEF2A (myocyte specific enhancer factor)
positively regulates genes of themTOR/S6K pathway, so it belongs
both to the mTOR core and module 7 (VEGF pathway) (Pereira
et al., 2009; Yin et al., 2012), promoting cell growth and dif-
ferentiation. However, the MEF2 family is also responsible for
cardiac hypertrophy and failure (Pereira et al., 2009), and its
overexpression leads to cardiac dysfunction.
MODULE SEVEN OF VEGF PATHWAY
Module 7 is associated with VEGF (vascular endothelial growth
factor) pathway-advancing cell growth, organ development, and
protein formation. This transcriptional module possesses four
transcription factors, namely, SP1, ESR1, E2F1, and EGR1, with
three first TFs tightly associated with the activities of the mTOR
pathway.
EGR1 (early-growth-response protein 1), which is module 7
specific TF, directs cell differentiation. It was discovered that its
level in a prostate cancer was raised, showing a pro-oncogenic
character; however, in other tumor types (skin tumor, fibrosar-
coma, and glioblastoma), EGR1 exhibits features of a tumor
suppressor by activating p53 and PTEN to halt the transcrip-
tion of other genes in the mTOR pathway (Zheng et al., 2009).
Moreover, it was discovered that the knockdown of EGR1 affects
VEGFA, thereby affecting the VEGF pathway and mitogenesis
(Abdel-Malak et al., 2009).
An E2F group affects activation of RPS6KB1 (S6K) and stim-
ulates phosphorylation of S6K and 4EBP in the presence of
Leucine. E2F1 integrates cell division (as well as cell growth) and
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induces an apoptotic response (Real et al., 2011). In tumor cells,
it can activate EGR1 to endorse cell survival. Moreover, in tumor
cells, by up-regulating the production of EGR1, epidermal growth
factor (EGFR), platelet-derived growth factor (PDGFRA), and
insulin-like growth factor II (IGF2BP2), E2F1 can activate the
phosphoinositide-3-kinase/Akt (PIK3CA/AKT) pathway in a way
to inhibit drug-induced apoptosis (Zheng et al., 2009).
DISCUSSION
Transcription factors selected (24 genes) from the results analysis
where those identified by main and supportive motifs discov-
ery tools used in our study (Supporting Figure 1). Other tran-
scription factors that less frequently appear can be seen in the
process-module-assigned fashion in Supporting Figures 1A,B for
human and mouse, respectively. Transcription factors (24) are
classified into two groups: first, those expressed in the specific
module of mTOR and second, those commonly identified in
various modules.
The first group of TFs includes ESR1, ELK1 (MAPK signaling,
module 1), FOXF2 (Insulin signaling, module 2), KLF4 (mTOR
core), ARNT (Hypoxia, module 4), E2F1, and EGR1 (VEGF
signaling, module 7). The second group includes SP1, MZF1,
PLAG1, TFAP1A, TBP, and RDS1. Among member of the second
group, MZF1, PLAG1, TFAP1A, and RDS are newly identified.
Other transcription factors identified in the promoters of genes
in our analysis are EGR2, EGR3, YY1, SREBF1, SREBF2, ELF1,
and ARID3A. They are less frequently share by the promoters in
our dataset but they are well-known to be involved in the mTOR
pathway regulation (YY1, SREBFs).
One-third (21) of the human transcription factors were found
to be conserved in the case of a mouse. Among them most con-
fident are SP1, TFAP2A, MZF1, EGR3, KLF4, USF1, KLF9, and
ARNT (Supporting Figure 1B). They are transcription factors
having multiple copies in gene promoters and/or shared by many
genes within the dataset. Cross-species-conserved TFs identified
corroborate the consistency of our methodology. However, a part
of frequently appearing mouse TFs, such as HSF1, CDC5L, HES6,
and FOXL1, were not identified in orthologous human promot-
ers. This might be regarding to the difference in the transcription
regulation between two species.
The results described in the paper indicate that the proper
selection of online motif-discovery tools without parameters
tuning is feasible to bring accurate results for the discovery
transcription regulation on medium size data. However the
aim to reduce false positives might result in the omitting low
sensitivity-degenerate motifs (Polouliakh et al., 2005). Creation
of sophisticated analytic workflow might be warranted to cope
with large-scale sequence data for de novo motif discovery.
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abstract
Supporting Figure 1 | Transcription-factor (TF) binding motifs in the mTOR
pathway identified in human (A) and mouse (B) orthologous datasets. The
intensity of the blue color reflects frequency of motif occurrence per
gene. The colors above transcription-factor names point to those
supportive programs (Cscan, LocaMo, TransFind, and TRAP), which also
identified a motif after it was detected by the five main programs
(MEME_Chip, PASTAA, Pscan, TFM-Explorer, and XXmotif). Transcription
factors were sorted according to the sum of occurrences in the whole
data set. The red horizontal line in the human-case results highlights 24
genes with average number of motifs per gene higher than 26 (Gene
threshold, Gene_TH), and the vertical red line shows the top-24
transcription factors (TF_TH) identified as the most significant in our study.
Sub-table (B) shows mouse transcription factors and genes in the same
order with the human ones and extended red lines from human data in
order to depict similarities between two species. Sub-table (C) includes
description of transcription factors and estimated positions of their motifs
in human promoters based on the results of the five main programs
(MEME_Chip, PASTAA, Pscan, TFM-Explorer, and XXmotif) and asterisks
point to human-mouse orthologous TFs.
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